Skip to content
SourceRX Sign in Apply
Menu

What is the difference between 503A and 503B?

Short answer

A 503A pharmacy compounds for an identified patient on a patient-specific prescription and answers mainly to its state board of pharmacy. A 503B outsourcing facility registers voluntarily with FDA, follows CGMP, and can supply healthcare providers without a patient-specific prescription. Direct-to-patient telehealth orders fit the 503A model.

By SourceRX. Last updated .

503A and 503B side by side

Question503A pharmacy503B outsourcing facility
LawFD&C Act section 503AFD&C Act section 503B, added by the Drug Quality and Security Act of 2013
PrescriptionValid and patient-specificPatient-specific prescription, or an order from a healthcare provider
CGMPExemptRequired
Main overseerState board of pharmacy, with FDA surveillance and for-cause inspectionsFDA, on a risk-based inspection schedule
StatusState-licensed pharmacy or physicianVoluntary category that reports adverse events and product information to FDA
FDA-approved product?NoNo
Typical customerAn individual patientHospitals, clinics and practices buying office stock

Which is safer, 503A or 503B?

Neither label answers that on its own. A 503B facility works to CGMP and FDA describes it as subject to increased quality standards. A 503A pharmacy works to state pharmacy rules and USP compounding chapters. FDA verifies the safety, effectiveness and quality of neither product before marketing, so check the specific pharmacy: its licenses, inspection history and testing.

Can a 503A pharmacy supply office stock?

Generally no. FDA says a prescription for office use does not meet the patient-specific requirement in section 503A. Where state law allows them, outsourcing facilities can fill orders from a healthcare provider.

Which model fits direct-to-patient telehealth?

503A, in most cases. A telehealth order starts with one patient, one prescriber and one prescription, and that is the shape section 503A was written around. A 503B facility’s advantage, supply without a patient-specific prescription, gives a direct-to-patient brand little it can use.

Does SourceRX work with 503B?

SourceRX storefronts run on the 503A model: every compounded order resolves to a recorded, patient-specific prescription before it can be filled. There is no 503B storefront type, because a gate built around naming a patient would produce a record that looks like compliance for an order that does not need one. See how the controls work.

Sources

  1. FDA, Human Drug Compounding Laws
  2. FDA, Compounding and the FDA: Questions and Answers
  3. 21 U.S.C. § 353a, Pharmacy compounding (FD&C Act section 503A)
  4. 21 U.S.C. § 353b, Outsourcing facilities (FD&C Act section 503B)

General information, not legal or medical advice. Rules vary by state and change over time, so have healthcare counsel review your plans.

Bring the brand. We run what sits underneath it.

SourceRX is approval only. Tell us about your business and the states you plan to ship to, and we review it before anyone gets access.

Apply for a store →